The project in a nutshell
Creating a new treatment of advanced/metastatic prostate cancer
that uses tiny nanoparticles to deliver both a drug that weakens
prostate cancer cells and standard chemotherapy drug docetaxel at
the same time.
Why we funded it
Currently docetaxel is one of the last treatment options
available for men with metastatic prostate cancer, but many develop
resistance to the drug. The results of this research could lead to
better results and longer survival for men with advanced prostate
cancer.
For more detailed information on this project, please look at
the lay
summary